Your browser doesn't support javascript.
loading
Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits.
Mikhaylov, Daniela; Hashim, Peter W; Nektalova, Tatyana; Goldenberg, Gary.
Affiliation
  • Mikhaylov D; Ms. Mikhaylov and Drs. Hashim, Nektalova, and Goldenberg are with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York.
  • Hashim PW; Dr. Goldenberg is also with Goldenberg Dermatology, PC, in New York, New York.
  • Nektalova T; Ms. Mikhaylov and Drs. Hashim, Nektalova, and Goldenberg are with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York.
  • Goldenberg G; Dr. Goldenberg is also with Goldenberg Dermatology, PC, in New York, New York.
J Clin Aesthet Dermatol ; 12(6): 46-54, 2019 Jun.
Article in En | MEDLINE | ID: mdl-31360288
ABSTRACT
Psoriasis is an inflammatory skin disease that is associated with many comorbidities. Several psoriasis treatments approved by the United States Food and Drug Administration have been shown to have beneficial effects on these comorbidities, while others might lead to an exacerbation of these conditions. In this article, we review studies of psoriasis treatments and their level of evidence for use in co-occurring diseases. An awareness of the multifaceted effects of certain psoriasis medications can enable physicians to provide more personalized treatment to their most complicated patients.
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: J Clin Aesthet Dermatol Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: J Clin Aesthet Dermatol Year: 2019 Document type: Article